Role of nicotinic acetylcholine receptors in cell proliferation and tumour invasion in broncho-pulmonary carcinomas

Lung Cancer

Volumn 87, Issue 3, 2015, Pages 258-264

  Medjber, Kahina ^a   Freidja, Mohamed Lamine ^a   Grelet, Simon ^a   Lorenzato, Marianne ^b   Maouche, Kamel ^a   Nawrocki Raby, Béatrice ^a   Birembaut, Philippe ^a,b   Polette, Myriam ^a,b   Tournier, Jean Marie ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Invasion; Nicotinic receptor; Non small cell lung cancer; Proliferation

Indexed keywords

BUNGAROTOXIN RECEPTOR; KI 67 ANTIGEN; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR BETA2; NICOTINIC RECEPTOR BETA4; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG ADENOCARCINOMA; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL LUNG CARCINOMA; TUMOR INVASION; DRUG EFFECTS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC;

EID: 84924067697     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.01.001     Document Type: Article

References (39)

1. Burns D.M. Tobacco-related diseases. Semin Oncol Nurs 2003, 19:244-249.
2. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999, 91:1194-1210.
3. Sobel A., Weber M., Changeux J.P. Large-scale purification of the acetylcholine-receptor protein in its membrane-bound and detergent-extracted forms from Torpedo marmorata electric organ. Eur J Biochem 1977, 80:215-224.
4. Galzi J.L., Revah F., Bessis A., Changeux J.P. Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain. Annu Rev Pharmacol Toxicol 1991, 31:37-72.
5. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 1995, 57:521-546.
6. Gotti C., Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 2004, 74:363-396.
7. Wang Y., Pereira E.F., Maus A.D., Ostlie N.S., Navaneetham D., Lei S., et al. Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol 2001, 60:1201-1209.
8. Tournier J.M., Maouche K., Coraux C., Zahm J.M., Cloez-Tayarani I., Nawrocki-Raby B., et al. alpha3alpha5beta2-Nicotinic acetylcholine receptor contributes to the wound repair of the respiratory epithelium by modulating intracellular calcium in migrating cells. Am J Pathol 2006, 168:55-68.
9. Kummer W., Lips K.S., Pfeil U. The epithelial cholinergic system of the airways. Histochem Cell Biol 2008, 130:219-234.
10. Maouche K., Polette M., Jolly T., Medjber K., Cloez-Tayarani I., Changeux J.P., et al. {alpha}7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation. Am J Pathol 2009, 175:1868-1882.
11. Codignola A., Tarroni P., Cattaneo M.G., Vicentini L.M., Clementi F., Sher E. Serotonin release and cell proliferation are under the control of alpha-bungarotoxin-sensitive nicotinic receptors in small-cell lung carcinoma cell lines. FEBS Lett 1994, 342:286-290.
12. West K.A., Brognard J., Clark A.S., Linnoila I.R., Yang X., Swain S.M., et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003, 111:81-90.
13. Trombino S., Cesario A., Margaritora S., Granone P., Motta G., Falugi C., et al. Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res 2004, 64:135-145.
14. Tsurutani J., Castillo S.S., Brognard J., Granville C.A., Zhang C., Gills J.J., et al. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis 2005, 26:1182-1195.
15. Dasgupta P., Rastogi S., Pillai S., Ordonez-Ercan D., Morris M., Haura E., et al. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest 2006, 116:2208-2217.
16. Ma X., Jia Y., Zu S., Li R., Jia Y., Zhao Y., et al. alpha5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1alpha and VEGF expression in non-small cell lung cancer. Toxicol Appl Pharmacol 2014, 278:172-179.
17. Jin Z., Gao F., Flagg T., Deng X. Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis. J Biol Chem 2004, 279:23837-23844.
18. Xu L., Deng X. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion. J Biol Chem 2004, 279:53683-53690.
19. Dasgupta P., Rizwani W., Pillai S., Kinkade R., Kovacs M., Rastogi S., et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 2008, 124:36-45.
20. Davis R., Rizwani W., Banerjee S., Kovacs M., Haura E., Coppola D., et al. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS ONE 2009, 4:e7524.
21. Krais A.M., Hautefeuille A.H., Cros M.P., Krutovskikh V., Tournier J.M., Birembaut P., et al. CHRNA5 as negative regulator of nicotine signaling in normal and cancer bronchial cells: effects on motility, migration and p63 expression. Carcinogenesis 2011, 32:1388-1395.
22. Shen J., Xu L., Owonikoko T.K., Sun S.Y., Khuri F.R., Curran W.J., et al. NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCiota/FAK loop. Cancer Lett 2012, 318:106-113.
23. Heeschen C., Jang J.J., Weis M., Pathak A., Kaji S., Hu R.S., et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001, 7:833-839.
24. Heeschen C., Weis M., Aicher A., Dimmeler S., Cooke J.P. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 2002, 110:527-536.
25. Lorenzato M., Caudroy S., Nou J.M., Dalstein V., Joseph K., Bellefqih S., et al. Contribution of DNA ploidy image cytometry to the management of ASC cervical lesions. Cancer 2008, 114:263-269.
26. Maouche K., Medjber K., Zahm J.M., Delavoie F., Terryn C., Coraux C., et al. Contribution of alpha7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. Proc Natl Acad Sci U S A 2013, 110:4099-4104.
27. Joannes A., Bonnomet A., Bindels S., Polette M., Gilles C., Burlet H., et al. Fhit regulates invasion of lung tumor cells. Oncogene 2010, 29:1203-1213.
28. Nguyen V.T., Chernyavsky A.I., Arredondo J., Bercovich D., Orr-Urtreger A., Vetter D.E., et al. Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 2004, 294:534-549.
29. Zia S., Ndoye A., Nguyen V.T., Grando S.A. Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res Commun Mol Pathol Pharmacol 1997, 97:243-262.
30. Maus A.D., Pereira E.F., Karachunski P.I., Horton R.M., Navaneetham D., Macklin K., et al. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 1998, 54:779-788.
31. Song P., Sekhon H.S., Jia Y., Keller J.A., Blusztajn J.K., Mark G.P., et al. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res 2003, 63:214-221.
32. Improgo M.R., Soll L.G., Tapper A.R., Gardner P.D. Nicotinic acetylcholine receptors mediate lung cancer growth. Front Physiol 2013, 4:251.
33. Grozio A., Paleari L., Catassi A., Servent D., Cilli M., Piccardi F., et al. Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: a promising prospective in anti-cancer drug development. Int J Cancer 2008, 122:1911-1915.
34. Schuller H.M. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors. Nat Rev Cancer 2009, 9:195-205.
35. Improgo M.R., Tapper A.R., Gardner P.D. Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. Biochem Pharmacol 2011, 82:1015-1021.
36. Schneider N.G., Olmstead R.E., Franzon M.A., Lunell E. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet 2001, 40:661-684.
37. Alama A., Bruzzo C., Cavalieri Z., Forlani A., Utkin Y., Casciano I., et al. Inhibition of the nicotinic acetylcholine receptors by cobra venom alpha-neurotoxins: is there a perspective in lung cancer treatment. PLoS ONE 2011, 6:e20695.
38. Cesario A., Russo P., Nastrucci C., Granone P. Is alpha7-nAChR a possible target for lung cancer and malignant pleural mesothelioma treatment. Curr Drug Targets 2012, 13:688-694.
39. Schuller H.M. Regulatory role of the alpha7nAChR in cancer. Curr Drug Targets 2012, 13:680-687.